The rapid spread of the highly contagious Omicron variant of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) along with its high number of mutations in the spike …

Since the emergence of SARS-CoV-2, vaccines targeting COVID-19 have been developed
with unprecedented speed and efficiency. CoronaVac, utilising an inactivated form of the …

Summary The 2013 Ebola epidemic in Central and West Africa heralded the emergence of
wide-spread, highly pathogenic viruses. The successful recombinant vector vaccine against …

Class I-and Class II-restricted epitopes have been identified across the SARS-CoV-2
structural proteome. Vaccine-induced and post-infection SARS-CoV-2 T-cell responses are …

Background: The adaptive immune response is a crucial component of the protective
immunity against SARS-CoV-2, generated after infection or vaccination. Methods: We …

Introduction We sought to determine pre-infection correlates of protection against SARS-
CoV-2 post-vaccine inzfections (PVI) acquired during the first Omicron wave in the United …

Human Ebola virus (EBOV) outbreaks caused by persistent EBOV infection raises questions
on the role of zoonotic spillover in filovirus epidemiology. To characterise filovirus zoonotic …

High-risk human papillomaviruses (HPVs) are considered risk factors in the origin of several
human malignancies, such as breast, cervical, head and neck, as well as colorectal cancers …

Background The risks and impact of COVID19 disease and vaccination in patients with
Immune Mediated Inflammatory Diseases (IMID) remain incompletely understood. IMID …

Antibodies represent a primary mediator of protection against respiratory viruses. Serum
neutralizing antibodies (NAbs) are often considered a primary correlate of protection …